1.Hatasaka H. The evaluation of abnormal uterine bleeding. Clin Obstet Gynecol 2005;48:258–73.
2.Goodwin SC, Spies JB, Worthington-Kirsch R, et al. Uterine artery embolization for treatment of leiomyomata: long-term outcomes from the FIBROID Registry. Obstet Gynecol 2008;111:22–33.
3.Marshall LM, Spiegelman D, Barbieri RL, et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol 1997;90:967–73.
4.Kim JJ, Sefton EC. The role of progesterone signaling in the pathogenesis of uterine leiomyoma. Mol Cell Endocrinol 2012;358:223–31.
5.Rein MS, Barbieri RL, Friedman AJ. Progesterone: a critical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol 1995;172:14–8.
6.Okolo S. Incidence, aetiology and epidemiology of uterine fibroids. Best Pract Res Clin Obstet Gynaecol 2008;22:571–88.
7.Levy B, Mukherjee T, Hirschhorn K. Molecular cytogenetic analysis of uterine leiomyoma and leiomyosarcoma by comparative genomic hybridization. Cancer Genet Cytogenet 2000;121:1–8.
8.Viswanathan M, Hartmann K, McKoy N, et al. Management of uterine fibroids: an update of the evidence. Evid Rep Technol Assess (Full Rep) 2007:1–122.
9.Marshall LM, Spiegelman D, Goldman MB, et al. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata. Fertil Steril 1998;70:432–9.
10.Sachan B, Idris Z, Jain S, Kumri R, A. S. Age at menarche and menstrual problems among school-going adolescent girls of a north Indian district.. Journal of Basic and Clinical Reproductive Sciences 2012;1:56–9.
11.Aryeetey R, Ashinyo A, Adjuik M. Age of menarche among basic level school girls in Medina, Accra. Afr J Reprod Health 2011;15:103–10.
12.Kadlubar FF, Berkowitz GS, Delongchamp RR, et al. The CYP3A4*1B variant is related to the onset of puberty, a known risk factor for the development of breast cancer. Cancer Epidemiol Biomarkers Prev 2003;12:327–31.
13.Choi JH, Yoo HW. Control of puberty: genetics, endocrinology, and environment. Curr Opin Endocrinol Diabetes Obes 2013;20:62–8.
14.Zhang XJ, Shen Q, Wang GY, et al. Risk factors for reproductive tract infections among married women in rural areas of Anhui Province, China. Eur J Obstet Gyn R B 2009;147:187–91.
15.Lisiecki M, Paszkowski M, Wozniak S. Fertility impairment associated with uterine fibroids - a review of literature. Prz Menopauzalny 2017;16:137–40.
16.Wegienka G, Baird DD, Hertz-Picciotto I, et al. Self-reported heavy bleeding associated with uterine leiomyomata. Obstet Gynecol 2003;101:431–7.
17.Lippman SA, Warner M, Samuels S, Olive D, Vercellini P, Eskenazi B. Uterine fibroids and gynecologic pain symptoms in a population-based study. Fertil Steril 2003;80:1488–94.
18.Ross RK, Pike MC, Vessey MP, Bull D, Yeates D, Casagrande JT. Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Br Med J (Clin Res Ed) 1986;293:359–62.
19.Faerstein E, Szklo M, Rosenshein N. Risk factors for uterine leiomyoma: a practice-based case-control study. I. African-American heritage, reproductive history, body size, and smoking. Am J Epidemiol 2001;153:1–10.
20.Ding CY, Wang J, Cao Y, et al. Heavy menstrual bleeding among women aged 18–50years living in Beijing, China: prevalence, risk factors, and impact on daily life. Bmc Womens Health 2019;19.
21.Ahrendt HJ, Tylkoski H, Rabe T, et al. Prevalence of uterine myomas in women in Germany: data of an epidemiological study. Arch Gynecol Obstet 2016;293:1243–53.
22.Zimmermann A, Bernuit D, Gerlinger C, Schaefers M, Geppert K. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women. Bmc Womens Health 2012;12:6.
23.Schwartz SM, Marshall LM, Baird DD. Epidemiologic contributions to understanding the etiology of uterine leiomyomata. Environ Health Perspect 2000;108 Suppl 5:821–7.
24.Montgomery GW, Zondervan KT, Nyholt DR. The future for genetic studies in reproduction. Mol Hum Reprod 2014;20:1–14.
25.Hodge JC, Cuenco KT, Huyck KL, et al. Uterine leiomyomata and decreased height: a common HMGA2 predisposition allele. Hum Genet 2009;125:257–63.
26.Rizzello A, Franck J, Pellegrino M, et al. A Proteomic Analysis of Human Uterine Myoma. Curr Protein Pept Sci 2017;18:167–74.
27.MacMahon B, Trichopoulos D, Brown J, et al. Age at menarche, urine estrogens and breast cancer risk. International journal of cancer 1982;30:427–31.
28.Apter D, Vihko R. Early menarche, a risk factor for breast cancer, indicates early onset of ovulatory cycles. J Clin Endocrinol Metab 1983;57:82–6.
29.Edwards DRV, Baird DD, Hartmann KE. Association of Age at Menarche With Increasing Number of Fibroids in a Cohort of Women Who Underwent Standardized Ultrasound Assessment. Am J Epidemiol 2013;178:426–33.
30.Wise LA, Palmer JR, Harlow BL, et al. Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study. Am J Epidemiol 2004;159:113–23.
31.Baird DD, Dunson DB. Why is parity protective for uterine fibroids? Epidemiology 2003;14:247–50.
32.Nezhat F, Datta MS, Hanson V, Pejovic T, Nezhat C, Nezhat C. The relationship of endometriosis and ovarian malignancy: a review. Fertil Steril 2008;90:1559–70.
33.Nezhat C, Li A, Abed S, et al. Strong Association Between Endometriosis and Symptomatic Leiomyomas. Jsls-J Soc Laparoend 2016;20.
34.Moore KR, Baird DD. Self-reported bacterial vaginosis and risk of ultrasound-diagnosed incident uterine fibroid cases in a prospective cohort study of young African American women. Ann Epidemiol 2017;27:749–51 e1.
35.Zhang L, Yu J-J. Logistic regression analysis of related risk factors of uterine fibroids. Journal of Southeast University(Medical Science Edition) 2012;31:213–6.
36.Guo L-X, Lu Z-L. Analysis of risk factors of uterine fibroids. Journal of Ningxia Medical University 2016;38:431–3.
37.Kato N, Hayasaka T, Takeda J, Osakabe M, Kurachi H. Ovarian tumors with functioning stroma: a clinicopathologic study with special reference to serum estrogen level, stromal morphology, and aromatase expression. Int J Gynecol Pathol 2013;32:556–61.
38.Jiao J, Sagnelli M, Shi B, et al. Genetic and epigenetic characteristics in ovarian tissues from polycystic ovary syndrome patients with irregular menstruation resemble those of ovarian cancer. Bmc Endocr Disord 2019;19.